The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels
Open accessAbstract
Significance: Voltage-gated sodium (Na v ) channels contribute to physiological and pathophysiological electrical signaling in nerve and muscle cells. Because Na v channel isoforms exhibit tissue-specific expression, subtype selective modulation of this channel family provides important drug development opportunities. However, most available Na v channel modulators are unable to distinguish between Na v channel subtypes, which limits their therapeutic utility because of cardiac or nervous system toxicity. This study describes a new class of subtype selective Na v channel inhibitors that interact with a region of the channel that controls voltage sensitivity. This interaction site may enable development of selective therapeutic interventions with reduced potential for toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since there is precedent for small molecule compounds that either enhance or diminish ion channel activity [60–62], it is conceivable to develop drugs for modulating NaV1.2 activity to treat IEE and ASD/ID.”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [60]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hodgkin, A. L., & Huxley, A. F. (1952) · The Journal of Physiology · doi:10.1113/jphysiol.1952.sp004764 · Cited by 23,191
An SCN9A channelopathy causes congenital inability to experience pain
Cox, J. J., Reimann, F. M., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,605
The crystal structure of a voltage-gated sodium channel
Payandeh, J., Scheuer, T., Zheng, N., & Catterall, W. A. (2011) · Nature · doi:10.1038/nature10238 · Cited by 1,453
Molecular Determinants of State-Dependent Block of Na + Channels by Local Anesthetics
Ragsdale, D. S., McPhee, J. C., Scheuer, T., & Catterall, W. A. (1994) · Science · doi:10.1126/science.8085162 · Cited by 839
Voltage‐gated sodium channels at 60: structure, function and pathophysiology
Catterall, W. A. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224204 · Cited by 728
Voltage-gated ion channels and gating modifier toxins
Catterall, W. A., Cestèle, S., Yarov-Yarovoy, V. M., Yu, F. H., Konoki, K., & Scheuer, T. (2006) · Toxicon · doi:10.1016/j.toxicon.2006.09.022 · Cited by 649
Ion Channel Voltage Sensors: Structure, Function, and Pathophysiology
Catterall, W. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.021 · Cited by 570
Ragsdale, D. S., McPhee, J. C., Scheuer, T., & Catterall, W. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9270 · Cited by 500
Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
Mantegazza, M., Curia, G., Biagini, G., Ragsdale, D. S., & Avoli, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70059-4 · Cited by 462
Rogers, J. C., Qu, Y., Tanada, T. N., Scheuer, T., & Catterall, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15950 · Cited by 411
Cited by
Sorted by citations
Items 201–268 of 268
Poslusney, M. S., Ernst, G. E., Huang, Y., Gerlach, A. C., Chapman, M. L., Santos, S. F. G., & Barrow, J. C. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.130059 · Cited by 3
Self-citationGarrison, C. E., Guan, W., Kato, M., Tamsett, T. J., Patel, T., Sun, Y., & Pathak, T. P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00415 · Cited by 3
Hadley, S. H., Patil, M. J., Pavelková, N., Kollárik, M., & Taylor‐Clark, T. E. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00199.2021 · Cited by 3
Technology, Science and Culture: A Global Vision, Volume IV
Hernández, L. R., & Meneses, M. A. S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.105162 · Cited by 3
Xie, Y., Yang, J., Ratté, S., & Prescott, S. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.04.510784 · Cited by 3
Thermally-induced neuronal plasticity that mediates heat tolerancePreprint
Ambroziak, W., Nencini, S., Pohle, J., Zuza, K., Pino, G., Lundh, S. H., Araujo-Sousa, C., Goetz, L. I. L., Schrenk-Siemens, K., Manoj, G., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.06.606929 · Cited by 3
NavDB: A Comprehensive Database for Voltage-Gated Sodium Channels Modulators and Targets
Wang, G., Yu, J., Chen, H., Luo, H. L., Pan, P., & Hou, T. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02124 · Cited by 2
The Voltage-Dependent Sodium Channel Family
Zaleska, M., Salvage, S. C., Thompson, A. J., Namadurai, S., Huang, C. L.-H., Wilkinson, T. C. I., Cusdin, F. S., & Jackson, A. P. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190669164.013.14 · Cited by 2
Pavelková, N., Brozmanová, M., Patil, M. J., & Kollárik, M. (2021) · Physiological Research · doi:10.33549/physiolres.934600 · Cited by 2
Ion Channels as Therapeutic Drug Targets
García, M. L., & Kaczorowski, G. J. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc255 · Cited by 2
Townsend, C. Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.99998-5 · Cited by 1
Docken, S. S., Clancy, C. E., & Lewis, T. J. (2023) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2023.111595 · Cited by 1
Chen, P., Lin, Y., Xia, M., Feng, H.-B., Pan, Y., Tan, Y., Xu, M., Xing, X.-H., Yao, X., Hu, B., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218226 · Cited by 1
Wang, Y.-Y., Wang, G.-A., You, Q., Liu, Y.-F., Qu, W.-L., Chen, Y.-H., Mu, C.-Z., Zhou, X. J., Liu, M., Yang, W., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01679-4 · Cited by 1
Ion Channel Drug Discovery: Future Perspectives
Gosling, M. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735087-00341 · Cited by 1
Yang, G., Wu, W., Li, Z., Chen, N., Qin, J., Hu, G., Zhang, Y., Li, J., & Chen, S. (2017) · Tetrahedron Letters · doi:10.1016/j.tetlet.2017.12.073 · Cited by 1
Makau, C. M., Towett, P. K., Kanui, T. I., & Abelson, K. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25274 · Cited by 1
Membrane Physiology and Biophysics—What Remains to Be Done?
Fahlke, C. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00892 · Cited by 1
Patel, R. R., Ping, X., Patel, S. R., McDermott, J. S., Krajewski, J. L., Chi, X. X., Nisenbaum, E. S., Jin, X., & Cummins, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.29.124693 · Cited by 1
Johnson, J. P., Focken, T., Tari, P. K., Dubé, C. M., Goodchild, S. J., Andrez, J., Bankar, G. R., Burford, K., Chang, E., Chowdhury, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.03.551823 · Cited by 1
A painful tale about synthetic scorpion toxins
Salvatierra, J., & Bosmans, F. (2016) · Channels · doi:10.1080/19336950.2016.1163956
Pike, A., Flanagan, N. J., Storer, R. I., Swain, N. A., & Tseng, E. (2018) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2156
Self-citationTownsend, C. Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00003-7
Technology, Science and Culture - A Global Vision, Volume IV
Hernández, L. R., & Meneses, M. A. S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.101948
Xie, Y., Yang, J., Ratté, S., & Prescott, S. A. (2023) · eLife · doi:10.7554/elife.90960.1
Xie, Y., Yang, J., Ratté, S., & Prescott, S. A. (2024) · eLife · doi:10.7554/elife.90960.2
Johnson, J. P., Cutts, A. J., Empfield, J. R., & Cohen, C. J. (2024) · doi:10.1093/med/9780197549469.003.0072
Sharma, S., Rana, P., Dhingra, N., & Kaur, T. (2025) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_347_24
Distinct mechanisms of inhibition of Kv2 potassium channels by tetraethylammonium and RY785Preprint
Zhang, S., Stix, R., Orabi, E. A., Bernhardt, N. A., & Faraldo-Gómez, J. (2026) · eLife · doi:10.7554/elife.101855.2
Rôles et régulations des canaux ioniques ASIC1b dans la douleur
Verkest, C. (2019) · theses.fr (ABES) · doi:10.70675/db17aabazd726z4d22zb273zf58b049ba711
Voltage-gated sodium channels in pain: Which channels, which blockers, and where NaV1.7 fits
Sutemieva, J., & Sobenin, D. V. (2026) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2026.04.001
A small molecule voltage-sensor modulator enhances the function of the cardiac NaV1.5 channel
Domingos, G., Fehér, Á. M., Teshome, R. T., Husain, S., Papp, F., Amna, A. O., Bangera, K. C., Vizi, Z., Elian, R., Kovács, Z. M., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119530
A Zebrafish Platform to Model Human SCN2A and SCN8A Epilepsy and Evaluate Anti-Seizure MedicationsPreprint
Milder, P. C., Cummins, T., & Marrs, J. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.21.733632
Wang, Y., Zheng, S., Xu, Z., Liu, X., Chen, Y., Cao, T., Wu, L., He, Z., Ge, Q., Ma, Y., et al. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.113142
Sodium ion channels as therapeutic targets in epilepsy: a drug discovery perspective
Kong, W., Lv, K., Gao, R., Liangju, H., Zhou, Y., Liu, X., Chen, D., Li, F., & Chen, W. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110297
Chen, K., He, X., Wang, G., Wu, H., Liu, X., Wang, L., Wu, Y., Liu, X., Shen, L., Gong, Y., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00882
Ligand-based pharmacophore modeling for the discovery of NaV1.7 inhibitors
Piga, M., Lukacs, P., Pesti, K., Várady, G., Varga, Z., Zidar, N., & Tomašič, T. (2026) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-026-00898-z
Modulation of human dorsal root ganglion neuron excitability by Nav1.7 inhibitionPreprint
Fujita, A., Jo, S., Stewart, R. G., Osorno, T., Ferraiuolo, A., Carlin, K., & Bean, B. P. (2026) · eLife · doi:10.7554/elife.111490.2
Shim, J. H., Lim, P., Woo, S., Han, J., & Kim, H. S. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c02422
Zhao, H., Liu, Z., Li, X.-M., Zhang, D., Liu, W., Liao, Z., Su, G.-J., Liu, Z., & Huang, X.-J. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168498
BindingDB Entry 50000210: Benzoxazolinone aryl sulfonamides as potent, selective Na
BindingDB (2019) · UC San Diego · doi:10.7270/q2sn0cd7
BindingDB Entry 50000083: Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na
BindingDB (2019) · UC San Diego · doi:10.7270/q29025xb
BindingDB Entry 50006220: Recent progress in sodium channel modulators for pain.
BindingDB (2020) · UC San Diego · doi:10.7270/q2ks6vjm
BindingDB Entry 50018140: Inhibition of Na
BindingDB (2024) · UC San Diego · doi:10.7270/q22f7snd
BindingDB Entry 50000820: Discovery of non-zwitterionic aryl sulfonamides as Na
BindingDB (2020) · UC San Diego · doi:10.7270/q20v8g8n
BindingDB Entry 50045956: N-Aryl azacycles as novel sodium channel blockers.
BindingDB (2016) · UC San Diego · doi:10.7270/q2862j67
BindingDB (2019) · UC San Diego · doi:10.7270/q21g0pqf
BindingDB Entry 50049251: Development of New Benzenesulfonamides As Potent and Selective Na
BindingDB (2019) · UC San Diego · doi:10.7270/q2057j69
BindingDB Entry 50013623: Identification of aryl sulfonamides as novel and potent inhibitors of Na
BindingDB (2022) · UC San Diego · doi:10.7270/q2cj8j7b
BindingDB Entry 50002554: Peptide therapeutics from venom: Current status and potential.
BindingDB (2020) · UC San Diego · doi:10.7270/q2q52s8q
BindingDB Entry 50007324: Discovery of new indole-based acylsulfonamide Na
BindingDB (2021) · UC San Diego · doi:10.7270/q2k64nc8
BindingDB Entry 50001978: Highly potent and selective Na
BindingDB (2020) · UC San Diego · doi:10.7270/q25q4zn1
BindingDB Entry 50049276: Sulfonamides as Selective Na
BindingDB (2019) · UC San Diego · doi:10.7270/q2rj4ms7
BindingDB Entry 50001046: The discovery of benzoxazine sulfonamide inhibitors of Na
BindingDB (2020) · UC San Diego · doi:10.7270/q2h134h4
BindingDB Entry 50002214: Discovery of morpholine-based aryl sulfonamides as Na
BindingDB (2020) · UC San Diego · doi:10.7270/q2jw8hg2
BindingDB Entry 50009631: Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective Na
BindingDB (2021) · UC San Diego · doi:10.7270/q2z32344
Metadata
- Authors
- McCormack, K., Santos, S., Chapman, M. L., Krafte, D. S., Marron, B. E., West, C. W., Krambis, M. J., Antonio, B. M., Zellmer, S. G., Printzenhoff, D., Padilla, K. M., Lin, Z., Wagoner, P. K., Swain, N. A., Stupple, P. A., de Groot, M., Butt, R. P., & Castle, N. A.
- Affiliations
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Pfizer Ltd., Sandwich, Kent CT13 9NJ, United Kingdom
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-07
- Volume
- 110
- Issue
- 29
- Pages
- E2724-32
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3718154
- OpenAlex
- W1979671751
- Cited by
- 244
- References
- 46
- Citations by year
- 2026: 15 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 20 · 2021: 19 · 2020: 19 · 2019: 14 · 2018: 24 · 2017: 33 · 2016: 22 · 2015: 13 · 2014: 15 · 2013: 2
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- voltage-gated sodium channels, small molecule inhibitors, subtype selectivity, Nav1.3, Nav1.7, cardiac sodium channel, toxin binding site, alpha-scorpion toxin, species sensitivity, sodium channel inactivation
- MeSH terms
- Acetamides, Binding Sites, Humans, Molecular Sequence Data, Thiazoles, Sequence Alignment, Patch-Clamp Techniques, Inhibitory Concentration 50, Amino Acid Motifs, Electrophysiological Phenomena, HEK293 Cells, Voltage-Gated Sodium Channel Blockers, NAV1.3 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review